A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring
Corina van den Hurk(Netherlands Comprehensive Cancer Organisation), Lonneke V. van de Poll‐Franse(Tilburg University), Annemarie Coolbrandt(KU Leuven), Floortje Mols(Tilburg University), Galina Velikova(University of Leeds), Raymond J. Chan(Flinders University), Doris Howell(Princess Margaret Cancer Centre), Bogda Koczwara(Flinders University), Manuela Eicher(University of Lausanne), Gijs Geleijnse(Netherlands Comprehensive Cancer Organisation), Iris Walraven(Radboud University Nijmegen), Andreas Charalambous(University of Turku), Annemarie Becker‐Commissaris(Amsterdam University Medical Centers), Maryam B. Lustberg(Yale Cancer Center), Ethan Basch(UNC Lineberger Comprehensive Cancer Center)
Cited by 60
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k